Chronic myeloid leukemia (CML) is a hematopoietic stem cell disorder characterized by the presence of the Philadelphia chromosome, a product of the reciprocal translocation t(9;22)(q34;q11), in the BCR and ABL genes. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.